{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:39:19Z","timestamp":1787729959932,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.pcad.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T01:20:41Z","timestamp":1613352041000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Femoral-popliteal peripheral artery disease: From symptom presentation to management and treatment controversies"],"prefix":"10.1016","volume":"65","author":[{"given":"Anna K.","family":"Krawisz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2021.02.004_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 Update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2021.02.004_bb0010","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.pcad.2021.02.004_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-5-14","article-title":"The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database","volume":"5","author":"Caro","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.pcad.2021.02.004_bb0020","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","article-title":"Evidence-based medical management of peripheral artery disease","volume":"40","author":"Bevan","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0030","first-page":"826","article-title":"The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study","volume":"54","author":"Dumville","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.pcad.2021.02.004_bb0035","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jvs.2009.07.109","article-title":"Impact of peripheral arterial disease on health status: a comparison with chronic heart failure","volume":"50","author":"Smolderen","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0040","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0045","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/radiology.183.3.1294068","article-title":"Femoral and popliteal arteries: reanalysis of results of balloon angioplasty","volume":"183","author":"Johnston","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.pcad.2021.02.004_bb0055","first-page":"910","article-title":"Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease","volume":"69","author":"Rocha-Singh","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.02.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011245","article-title":"Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK","volume":"6","author":"Katsanos","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.pcad.2021.02.004_bb0065","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0070","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Konstantinos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2021.02.004_bb0075","author":"McKeown"},{"key":"10.1016\/j.pcad.2021.02.004_bb0080","first-page":"18","article-title":"The market reacts quickly: changes in paclitaxel vascular device purchasing within the ascension healthcare system","volume":"32","author":"Monteleone","year":"2020","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0085","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.pcad.2021.02.004_bb0095","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease","volume":"65","author":"Patel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.atherosclerosis.2018.05.033","article-title":"Update on peripheral artery disease: epidemiology and evidence-based facts","volume":"275","author":"Shu","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2021.02.004_bb0105","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2021.02.004_bb0110","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1161\/CIRCULATIONAHA.105.546507","article-title":"Ethnicity and peripheral arterial disease","volume":"112","author":"Criqui","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2021.02.004_bb0115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4065\/mcp.2010.0133","article-title":"Peripheral artery disease: current insight into the disease and its diagnosis and management","volume":"85","author":"Olin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pcad.2021.02.004_bb0120","first-page":"218","article-title":"Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation","volume":"11","author":"Novo","year":"1992","journal-title":"Int Angiol J Int Union Angiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0125","series-title":"StatPearls","article-title":"Peripheral arterial disease","author":"Zemaitis","year":"2020"},{"key":"10.1016\/j.pcad.2021.02.004_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1191\/1358863x03vm483ra","article-title":"Functional outcomes and quality of life in peripheral arterial disease: current status","volume":"8","author":"Nehler","year":"2003","journal-title":"Vasc Med Lond Engl"},{"key":"10.1016\/j.pcad.2021.02.004_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/VHRM.S209241","article-title":"The burden of critical limb ischemia: a review of recent literature","volume":"15","author":"Duff","year":"2019","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.004_bb0145","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0034-1393976","article-title":"Overview of classification systems in peripheral artery disease","volume":"31","author":"Hardman","year":"2014","journal-title":"Semin Interv Radiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/clc.22406","article-title":"Comparative effectiveness of medical therapy, supervised exercise, and revascularization for patients with intermittent claudication: a network meta-analysis","volume":"38","author":"Vemulapalli","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2261-9-9","article-title":"Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication","volume":"9","author":"Kruidenier","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.pcad.2021.02.004_bb0165","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jvs.2012.07.051","article-title":"Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease","volume":"57","author":"Leeper","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.114.013268","article-title":"Response to letter regarding article, \u201csix-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease\u201d","volume":"131","author":"McDermott","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2021.02.004_bb0175","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1532-5415.1998.tb03804.x","article-title":"The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients","volume":"46","author":"Montgomery","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pcad.2021.02.004_bb0180","article-title":"Assessing health-related quality of life among patients with peripheral artery disease: a review of the literature and focus on patient-reported outcome measures","author":"Raja","year":"2020","journal-title":"Vasc Med Lond Engl"},{"key":"10.1016\/j.pcad.2021.02.004_bb0185","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0741-5214(03)00312-4","article-title":"Evaluating effects of method of administration on walking impairment questionnaire","volume":"38","author":"Coyne","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0190","first-page":"301","article-title":"The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease","volume":"147","author":"Spertus","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2021.02.004_bb0195","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: a randomized clinical trial","volume":"65","author":"Murphy","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jvir.2014.09.018","article-title":"S.M.A.R.T. Self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes","volume":"26","author":"Gray","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0205","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/j.jvs.2010.01.076","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis","volume":"51","author":"Forbes","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2021.02.004_bb0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/eci.12407","article-title":"Local delivery of paclitaxel in the treatment of peripheral arterial disease","volume":"45","author":"Ng","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pcad.2021.02.004_bb0220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2021.02.004_bb0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.02.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.02.004_bb0235","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-Year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2021.02.004_bb0240","author":"U.S. Food & Drug Administration"},{"key":"10.1016\/j.pcad.2021.02.004_bb0250","series-title":"UPDATE: Treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality","author":"Health, C. for D. and R","year":"2019"},{"key":"10.1016\/j.pcad.2021.02.004_bb0255","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2021.02.004_bb0265","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0270","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2019.02.020","article-title":"Drug-eluting stent implantation and long-term survival following peripheral artery revascularization","volume":"73","author":"Secemsky","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.02.004_bb0280","article-title":"Long-Term Safety of Drug-Coated Devices for Peripheral Revascularisation","author":"Secemsky","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2021.02.004_bb0285","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","author":"Freisinger","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2021.02.004_bb0290","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jvs.2020.03.005","article-title":"Long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"71","author":"Behrendt","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.02.004_bb0295","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2021.02.004_bb0300","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2021.02.004_bb0305","series-title":"Long-term safety of drug-coated devices for peripheral artery revascularization: Insights from voyager-PAD","article-title":"TCT connect 2020: late breaking clinical trials and science","author":"Hess","year":"2020"},{"key":"10.1016\/j.pcad.2021.02.004_bb0310","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.18203\/2320-6012.ijrms20181743","article-title":"Peripheral stent technology and current status for endovascular treatment of femoropopliteal artery disease: a clinical review","volume":"6","author":"Dave","year":"2018","journal-title":"Int J Res Med Sci"},{"key":"10.1016\/j.pcad.2021.02.004_bb0315","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jcin.2020.04.050","article-title":"Evaluation of mortality following paclitaxel drug-coated balloon angioplasty of femoropopliteal lesions in the real world","volume":"13","author":"B\u00f6hme","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.02.004_bb0320","series-title":"Catheterization and cardiovascular interventions","article-title":"Evaluation of mortality following paclitaxel drug-coated stent angioplasty of femoropopliteal lesions in real world","year":"2020"},{"key":"10.1016\/j.pcad.2021.02.004_bb0325","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ahj.2020.12.004","article-title":"Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients \u226565 years old: an ACC PVI registry analysis","volume":"233","author":"Weissler","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2021.02.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","article-title":"Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the vascular quality initiative","volume":"13","author":"Bertges","year":"2020","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:17:32Z","timestamp":1758500252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062021000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"alternative-id":["S0033062021000189"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2021.02.004","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Femoral-popliteal peripheral artery disease: From symptom presentation to management and treatment controversies","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}